220 related articles for article (PubMed ID: 33039254)
1. Central and local controls of monocytopoiesis influence the outcome of Leishmania infection.
Raybarman C; Bhattacharjee S
Cytokine; 2021 Nov; 147():155325. PubMed ID: 33039254
[TBL] [Abstract][Full Text] [Related]
2. New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.
Vellozo NS; Rigoni TS; Lopes MF
Front Immunol; 2021; 12():704429. PubMed ID: 34249011
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in the immunity and immunopathogenesis in leishmaniases.
Saha B; Silvestre R
Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection.
Bodhale N; Ohms M; Ferreira C; Mesquita I; Mukherjee A; André S; Sarkar A; Estaquier J; Laskay T; Saha B; Silvestre R
Cytokine; 2021 Nov; 147():155267. PubMed ID: 32917471
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.
Reis LC; Ramos-Sanchez EM; Araujo FN; Leal AF; Ozaki CY; Sevillano OR; Uscata BA; Goto H
J Immunol Res; 2021; 2021():6614475. PubMed ID: 34036108
[TBL] [Abstract][Full Text] [Related]
6. Leishmania species-dependent functional duality of toll-like receptor 2.
Jafarzadeh A; Nemati M; Sharifi I; Nair A; Shukla D; Chauhan P; Khorramdelazad H; Sarkar A; Saha B
IUBMB Life; 2019 Nov; 71(11):1685-1700. PubMed ID: 31329370
[TBL] [Abstract][Full Text] [Related]
7. Host susceptibility factors to cutaneous leishmaniasis.
Jones DE; Elloso MM; Scott P
Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
[TBL] [Abstract][Full Text] [Related]
8. Regulator and effector functions of T-cell subsets in human Leishmania infections.
Kemp M
APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in host-parasite interactions in leishmaniasis.
Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
[TBL] [Abstract][Full Text] [Related]
10. Exploring the paradox of defense between host and Leishmania parasite.
Kumari D; Singh K
Int Immunopharmacol; 2022 Jan; 102():108400. PubMed ID: 34890999
[TBL] [Abstract][Full Text] [Related]
11. The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response.
Liu D; Uzonna JE
Front Cell Infect Microbiol; 2012; 2():83. PubMed ID: 22919674
[TBL] [Abstract][Full Text] [Related]
12. Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.
Silverman JM; Reiner NE
Front Cell Infect Microbiol; 2011; 1():26. PubMed ID: 22919591
[TBL] [Abstract][Full Text] [Related]
13. A historical review of the role of cytokines involved in leishmaniasis.
Mirzaei A; Maleki M; Masoumi E; Maspi N
Cytokine; 2021 Sep; 145():155297. PubMed ID: 32972825
[TBL] [Abstract][Full Text] [Related]
14. A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.
Roy S; Mukhopadhyay D; Mukherjee S; Ghosh S; Kumar S; Sarkar K; Pal D; Bhowmik P; Mandal K; Modak D; Guha SK; Pramanik N; Goswami RP; Saha B; Chatterjee M
J Clin Immunol; 2015 Jan; 35(1):56-67. PubMed ID: 25479930
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Leishmania with the host macrophage.
Handman E; Bullen DV
Trends Parasitol; 2002 Aug; 18(8):332-4. PubMed ID: 12377273
[TBL] [Abstract][Full Text] [Related]
16. Parasite-monocyte interactions in human leishmaniasis: production of interleukin-1 in vitro.
Crawford GD; Wyler DJ; Dinarello CA
J Infect Dis; 1985 Aug; 152(2):315-22. PubMed ID: 3875664
[TBL] [Abstract][Full Text] [Related]
17. Th1-Th2 Cross-Regulation Controls Early Leishmania Infection in the Skin by Modulating the Size of the Permissive Monocytic Host Cell Reservoir.
Carneiro MB; Lopes ME; Hohman LS; Romano A; David BA; Kratofil R; Kubes P; Workentine ML; Campos AC; Vieira LQ; Peters NC
Cell Host Microbe; 2020 May; 27(5):752-768.e7. PubMed ID: 32298657
[TBL] [Abstract][Full Text] [Related]
18. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
Chang KP; Reed SG; McGwire BS; Soong L
Acta Trop; 2003 Mar; 85(3):375-90. PubMed ID: 12659975
[TBL] [Abstract][Full Text] [Related]
19. How to master the host immune system? Leishmania parasites have the solutions!
Rossi M; Fasel N
Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
[TBL] [Abstract][Full Text] [Related]
20. Transgenic Leishmania and the immune response to infection.
Beattie L; Evans KJ; Kaye PM; Smith DF
Parasite Immunol; 2008 Apr; 30(4):255-66. PubMed ID: 18266814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
